PriceTargets.com logo

Cutera - CUTR Stock Price Target and Predictions

  • Consensus Rating: Buy
  • Consensus Price Target: $56.20
  • Forecasted Upside: 58.80%
  • Number of Analysts: 5
  • Breakdown:
  • 0 Sell Ratings
  • 2 Hold Ratings
  • 3 Buy Ratings
  • 0 Strong Buy Ratings
$35.39 As of 02/7/2023 01:00 AM ET
▼ -0.78 (-2.16%)

This chart shows the closing price for CUTR by one month, three months, or twelve months.

Skip Closing Price Chart
1 month | 3 months | 12 months
Get New Cutera Analyst Ratings Delivered To Your Inbox
Sign-up to receive the latest news and ratings for CUTR and its competitors with Analyst Ratings Network’s free daily newsletter.

Analyst Price Target for CUTR

Analyst Price Target is $56.20
▲ +58.80% Upside Potential
This price target is based on 5 analysts offering 12 month price targets for Cutera in the last 3 months. The average price target is $56.20, with a high forecast of $70.00 and a low forecast of $33.00. The average price target represents a 58.80% upside from the last price of $35.39.

This chart shows the closing price for CUTR for the last year in relation to the current analyst high, average, and low pricetarget.

Read Analyst Price Chart DescriptionSkip Analyst Price Chart

Current Consensus is Buy

The current consensus among 5 investment analysts is to buy stock in Cutera. This Buy consensus rating has held steady for over two years.

Past Monthly Recommendations

Move your mouse over past months for details

Read Past Recommendations DescriptionSkip Past Price Target Consensus Chart
  • 0 strong buy ratings
  • 2 buy ratings
  • 1 hold ratings
  • 0 sell ratings
Ratings as of
8/16/2021
  • 0 strong buy ratings
  • 2 buy ratings
  • 1 hold ratings
  • 0 sell ratings
Ratings as of
11/14/2021
  • 0 strong buy ratings
  • 2 buy ratings
  • 1 hold ratings
  • 0 sell ratings
Ratings as of
2/12/2022
  • 0 strong buy ratings
  • 2 buy ratings
  • 1 hold ratings
  • 0 sell ratings
Ratings as of
5/13/2022
  • 0 strong buy ratings
  • 2 buy ratings
  • 0 hold ratings
  • 0 sell ratings
Ratings as of
8/11/2022
  • 0 strong buy ratings
  • 3 buy ratings
  • 0 hold ratings
  • 0 sell ratings
Ratings as of
11/9/2022
  • 0 strong buy ratings
  • 3 buy ratings
  • 0 hold ratings
  • 0 sell ratings
Ratings as of
1/8/2023
  • 0 strong buy ratings
  • 3 buy ratings
  • 2 hold ratings
  • 0 sell ratings
Ratings as of
2/7/2023

Latest Recommendations

  • 0 strong buy ratings
  • 3 buy ratings
  • 2 hold ratings
  • 0 sell ratings

Display Ratings By
DateBrokerageActionRatingPrice TargetImpact on Share PriceDetails
1/31/2023William BlairInitiated CoverageMarket PerformLow
1/12/2023Maxim GroupLower TargetBuy$80.00 ➝ $55.00Low
1/11/2023Cantor FitzgeraldDowngradeOverweight ➝ Neutral$85.00 ➝ $33.00Low
12/28/2022StephensLower TargetOverweight$78.00 ➝ $68.00Low
10/13/2022StephensInitiated CoverageOverweight$78.00Low
8/5/2022Maxim GroupReiterated RatingBuy$80.00Low
8/5/2022Piper SandlerLower TargetOverweight$65.00 ➝ $55.00Low
5/9/2022StephensBoost Target$68.00 ➝ $78.00High
5/5/2022Maxim GroupBoost Target$60.00 ➝ $80.00Medium
3/28/2022Stifel NicolausBoost Target$60.00 ➝ $70.00High
11/4/2021Maxim GroupUpgradeHold ➝ Buy$60.00High
8/5/2021Piper SandlerBoost TargetOverweight$42.00 ➝ $65.00High
7/13/2021Cantor FitzgeraldBoost TargetOverweight$55.00 ➝ $60.00Low
6/2/2021Cantor FitzgeraldInitiated CoverageOverweight$55.00High
3/5/2021Piper SandlerBoost TargetOverweight$38.00 ➝ $42.00High
2/18/2021Piper SandlerBoost TargetOverweight$28.00 ➝ $38.00High
11/5/2020Piper SandlerBoost TargetOverweight$22.00 ➝ $28.00High
9/30/2020Piper SandlerBoost TargetOverweight$18.00 ➝ $22.00High
9/14/2020StephensBoost TargetOverweight$18.00 ➝ $24.00High
5/8/2020Maxim GroupReiterated RatingHoldLow
5/5/2020Stifel NicolausUpgradeHold ➝ Buy$32.00 ➝ $26.00High
4/22/2020Piper SandlerInitiated CoverageOverweight$18.00Low
3/23/2020StephensLower TargetOverweight$45.00 ➝ $15.00High
2/28/2020Maxim GroupReiterated RatingHoldMedium
11/8/2019StephensBoost TargetOverweight$35.00 ➝ $45.00High
8/22/2019SidotiDowngradeBuy ➝ NeutralHigh
8/9/2019Maxim GroupReiterated RatingHoldLow
2/21/2019StephensLower TargetOverweight$40.00 ➝ $25.00High
2/11/2019Maxim GroupReiterated RatingHoldMedium
1/8/2019Maxim GroupReiterated RatingHoldHigh
10/5/2018SidotiSet TargetBuy$50.00High
10/5/2018StephensLower TargetUnderperform ➝ Sell$40.00 ➝ $24.94High
10/5/2018Stifel NicolausLower TargetHold ➝ Hold$45.00 ➝ $29.00High
8/8/2018Stifel NicolausLower TargetHold ➝ Hold$55.00 ➝ $45.00High
4/16/2018Stifel NicolausInitiated CoverageHold ➝ Hold$55.00High
3/13/2018StephensInitiated CoverageOverweight$60.00High
2/16/2018GabelliReiterated RatingBuyLow
(Data available from 2/7/2018 forward)

News Sentiment Rating

0.52 (Buy)

Our news sentiment rating is based on the average sentiment of articles about this company published in the media in the last 30 days of headlines and can range from 2 (very positive sentiment) to -2 (very negative sentiment).

News Sentiment Over Time

Move your mouse over past months for details

Skip to Current Sentiment Summary
  • 0 very positive mentions
  • 2 positive mentions
  • 0 negative mentions
  • 2 very negative mentions
Mentions as of
7/12/2022
  • 4 very positive mentions
  • 19 positive mentions
  • 0 negative mentions
  • 2 very negative mentions
Mentions as of
8/11/2022
  • 2 very positive mentions
  • 8 positive mentions
  • 1 negative mentions
  • 0 very negative mentions
Mentions as of
9/10/2022
  • 0 very positive mentions
  • 6 positive mentions
  • 0 negative mentions
  • 0 very negative mentions
Mentions as of
10/10/2022
  • 3 very positive mentions
  • 6 positive mentions
  • 2 negative mentions
  • 0 very negative mentions
Mentions as of
11/9/2022
  • 4 very positive mentions
  • 4 positive mentions
  • 0 negative mentions
  • 0 very negative mentions
Mentions as of
12/9/2022
  • 2 very positive mentions
  • 0 positive mentions
  • 0 negative mentions
  • 0 very negative mentions
Mentions as of
1/8/2023
  • 2 very positive mentions
  • 4 positive mentions
  • 1 negative mentions
  • 0 very negative mentions
Mentions as of
2/7/2023

Current Sentiment

  • 2 very positive mentions
  • 4 positive mentions
  • 1 negative mentions
  • 0 very negative mentions

Recent Stories by Sentiment

Very Negative

  • No very negative mentions tracked during this time.

Negative

Positive

Very Positive

Cutera logo
Cutera, Inc. engages in the provision of laser and energy-based aesthetic systems for practitioners. It operates through the following segments: United States, Japan, Asia excluding Japan, Europe, and Rest of the World. Its products include enlighten, excel HR, excel V+, secret Pro, Juliet, secret RF, and xeo. The company was founded by David A. Gollnick in August 1998 and is headquartered in Brisbane, CA.
Read More

Today's Range

Now: $35.39
Low: $34.87
High: $36.25

50 Day Range

MA: $40.38
Low: $27.79
High: $51.65

52 Week Range

Now: $35.39
Low: $26.51
High: $74.38

Volume

354,852 shs

Average Volume

662,558 shs

Market Capitalization

$694.00 million

P/E Ratio

N/A

Dividend Yield

N/A

Beta

1.58

Frequently Asked Questions

What sell-side analysts currently cover shares of Cutera?

The following sell-side analysts have issued stock ratings on Cutera in the last twelve months: Cantor Fitzgerald, Maxim Group, Piper Sandler, Stephens, Stifel Nicolaus, StockNews.com, TheStreet, and William Blair.
View the latest analyst ratings for CUTR.

What is the current price target for Cutera?

5 Wall Street analysts have set twelve-month price targets for Cutera in the last year. Their average twelve-month price target is $56.20, suggesting a possible upside of 58.8%. Stifel Nicolaus has the highest price target set, predicting CUTR will reach $70.00 in the next twelve months. Cantor Fitzgerald has the lowest price target set, forecasting a price of $33.00 for Cutera in the next year.
View the latest price targets for CUTR.

What is the current consensus analyst rating for Cutera?

Cutera currently has 2 hold ratings and 3 buy ratings from Wall Street analysts. The stock has a consensus analyst rating of "Buy." A "buy" rating indicates that analysts believe CUTR will outperform the market and that investors should add to their positions of Cutera.
View the latest ratings for CUTR.

What other companies compete with Cutera?

Other companies that are similar to Cutera include ACM Research, Nano Dimension, Cass Information Systems, Anterix and Navitas Semiconductor. Learn More about companies similar to Cutera.

How do I contact Cutera's investor relations team?

Cutera's physical mailing address is 3240 BAYSHORE BOULEVARD, BRISBANE CA, 94005. The medical device company's listed phone number is (415) 657-5500 and its investor relations email address is [email protected] The official website for Cutera is www.cutera.com. Learn More about contacing Cutera investor relations.